These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35990718)

  • 1. 6th Canadian Symposium on Hepatitis C Virus: Delivering a cure for hepatitis C infection-What are the remaining gaps?
    Khan S; Bernier A; Dapp D; Fortier E; Krajden M; King A; Grebely J; Sagan SM; Cooper CL; Crawley AM
    Can Liver J; 2018; 1(2):94-105. PubMed ID: 35990718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 9th Canadian Symposium on Hepatitis C Virus: Advances in HCV research and treatment towards elimination.
    Li J; Casey JL; Greenwald ZR; Yasseen Iii AS; Dickie M; Feld JJ; Cooper CL; Crawley AM
    Can Liver J; 2021; 4(1):59-71. PubMed ID: 35991475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 8
    Cousineau SE; Erman A; Liu L; Saeed S; Fradette L; Feld JJ; Grebely J; MacParland SA; Shoukry NH; Sebastiani G; Sagan SM;
    Can Liver J; 2020; 3(1):3-14. PubMed ID: 35992037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 11th Canadian Symposium on Hepatitis C Virus: 'Getting back on track towards hepatitis C elimination'.
    Passos-Castilho AM; Udhesister STP; Fontaine G; Jeong D; Dickie M; Lund C; Russell R; Kronfli N
    Can Liver J; 2023 Feb; 6(1):56-69. PubMed ID: 36908576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 7th Canadian Symposium on Hepatitis C Virus: "Toward Elimination of HCV: How to Get There".
    Cheng ML; Abdel-Hakeem MS; Cousineau SE; Grebely J; Marshall AD; Saeed S; Sagan SM; Shoukry NH; Feld JJ; MacParland SA
    Can Liver J; 2018; 1(3):139-152. PubMed ID: 35991324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of HCV with direct-acting antivirals on reducing mortality related to extrahepatic manifestations: a large population-based study in British Columbia, Canada.
    Jeong D; Wong S; Karim ME; Manges AR; Makuza JD; Bartlett SR; Velásquez García HA; Luster D; Adu PA; Binka M; Yu A; Krajden M; Janjua NZ
    Lancet Reg Health Am; 2024 Jan; 29():100658. PubMed ID: 38235369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 5th Canadian Symposium on Hepatitis C Virus: We Are Not Done Yet-Remaining Challenges in Hepatitis C.
    van Buuren N; Fradette L; Grebely J; King A; Krajden M; MacParland SA; Marshall A; Saeed S; Wilson J; Klein MB; Sagan SM
    Can J Gastroenterol Hepatol; 2016; 2016():7603526. PubMed ID: 27843889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada.
    Saeed S; Strumpf EC; Moodie EE; Young J; Nitulescu R; Cox J; Wong A; Walmsely S; Cooper C; Vachon ML; Martel-Laferriere V; Hull M; Conway B; Klein MB;
    J Int AIDS Soc; 2017 Nov; 20(3):. PubMed ID: 29116684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.
    Seeff LB; Hoofnagle JH
    Clin Liver Dis; 2003 Feb; 7(1):261-87. PubMed ID: 12691470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct-Acting Antivirals Improve Access to Care and Cure for Patients With HIV and Chronic HCV Infection.
    Collins LF; Chan A; Zheng J; Chow SC; Wilder JM; Muir AJ; Naggie S
    Open Forum Infect Dis; 2018 Jan; 5(1):ofx264. PubMed ID: 29308413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses.
    Shin EC; Han JW; Kang W; Kato T; Kim SJ; Zhong J; Kim S; Park SH; Sung PS; Watashi K; Park JY; Windisch MP; Oh JW; Wakita T; Han KH; Jang SK
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32168867
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidemiology and natural history of hepatitis C virus infection among children and young people.
    Modin L; Arshad A; Wilkes B; Benselin J; Lloyd C; Irving WL; Kelly DA
    J Hepatol; 2019 Mar; 70(3):371-378. PubMed ID: 30496763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver Fibrosis in Human Immunodeficiency Virus (HIV)-Hepatitis C Virus (HCV) Coinfection Before and After Sustained Virologic Response: What Is the Best Noninvasive Marker for Monitoring Regression?
    Kronfli N; Young J; Wang S; Cox J; Walmsley S; Hull M; Cooper C; Martel-Laferriere V; Wong A; Pick N; Klein MB;
    Clin Infect Dis; 2021 Aug; 73(3):468-477. PubMed ID: 32504083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C Virus Infection Outcomes Among Immigrants to Canada: A Retrospective Cohort Analysis.
    Cooper CL; Thavorn K; Damian E; Corsi DJ
    Ann Hepatol; 2017; 16(5):720-726. PubMed ID: 28809741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A platform in the use of medicines to treat chronic hepatitis C (PLATINUM C): protocol for a prospective treatment registry of real-world outcomes for hepatitis C.
    Ramsay J; Marsh J; Pedrana A; Andric N; Norman R; Cheng W; Webb S; Zeps N; Bellgard M; Graves T; Hellard M; Snelling T
    BMC Infect Dis; 2020 Oct; 20(1):802. PubMed ID: 33121439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
    Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M
    J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals.
    Prenner SB; VanWagner LB; Flamm SL; Salem R; Lewandowski RJ; Kulik L
    J Hepatol; 2017 Jun; 66(6):1173-1181. PubMed ID: 28161470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs.
    Day E; Broder T; Bruneau J; Cruse S; Dickie M; Fish S; Grillon C; Luhmann N; Mason K; McLean E; Trooskin S; Treloar C; Grebely J
    Int J Drug Policy; 2019 Apr; 66():87-93. PubMed ID: 30743093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower Risk of Hepatocellular Carcinoma After Sustained Virological Response to Direct-acting Antivirals in Hepatitis C Infected Patients With Advanced Fibrosis.
    Corma-Gómez A; Macías J; Lacalle-Remigio JR; Téllez F; Morano L; Rivero A; Serrano M; Ríos MJ; Vera-Méndez FJ; Alados JC; Real LM; Palacios R; Santos IL; Imatz A; Pineda JA;
    Clin Infect Dis; 2021 Oct; 73(7):e2109-e2116. PubMed ID: 32766891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.